MK-383 prodrug

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameMK-383 prodrug
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-IIb/beta-3 antagonists
TargetsIntegrin alpha-IIb/beta-3
Therapy Area/IndicationsThromboembolism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNorth Carolina State University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNorth Carolina State University
Active IndicationsN/A
Inactive IndicationsThromboembolism

Other Information

ATC CodeN/A
Related LinksN/A